<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Sterilization failure rates compared with long-acting reversible contraceptives</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Sterilization failure rates compared with long-acting reversible contraceptives</h1>
<div class="graphic"><div class="figure"><div class="ttl">Sterilization failure rates compared with long-acting reversible contraceptives</div><div class="cntnt"><table cellspacing="0"><colgroup span="4" width="20%"></colgroup> <tbody> <tr> <td class="subtitle1 border_bottom_thick" rowspan="2">Contraceptive method</td> <td class="subtitle1 divider_bottom" colspan="3">Pregnancies per 1000 procedures (follow-up interval in years)</td> </tr> <tr class="border_bottom_thick"> <td class="subtitle2">1 to 2 years</td> <td class="subtitle2">3 to 5 years</td> <td class="subtitle2">7 to 12 years</td> </tr> <tr> <td class="subtitle2_left" colspan="4">Female permanent contraception</td> </tr> <tr> <td class="indent1" colspan="4"><strong>Postpartum permanent contraception</strong></td> </tr> <tr> <td class="indent2">Postpartum partial salpingectomy</td> <td class="centered">1.2 (1)</td> <td class="centered">6.3 (5)</td> <td class="centered">7.5 (10)</td> </tr> <tr> <td class="indent2">Postpartum titanium clips (Filshie clips)</td> <td class="centered">17 (2)</td> <td class="centered">–</td> <td class="centered">–</td> </tr> <tr> <td class="indent1" colspan="4"><strong>Interval permanent contraception</strong></td> </tr> <tr> <td class="indent2">Interval partial salpingectomy</td> <td class="centered">7.3 (1)</td> <td class="centered">15.1 (5)</td> <td class="centered">20.1 (10)</td> </tr> <tr> <td class="indent2">Interval titanium clips (Filshie clips)</td> <td class="centered">4 (2)</td> <td class="centered">–</td> <td class="centered">–</td> </tr> <tr> <td class="indent2">Silicone rubber band (Falope Ring)</td> <td class="centered">3 (1 to 2)</td> <td class="centered">10 (5)</td> <td class="centered">17.7 (10)</td> </tr> <tr> <td class="indent2">Electrosurgery</td> <td class="centered">–</td> <td class="centered">3.2* (5)</td> <td class="centered">–</td> </tr> <tr> <td class="subtitle2_left" colspan="4">Male permanent contraception</td> </tr> <tr> <td class="indent1">Vasectomy</td> <td class="centered">1.5 (2)</td> <td class="centered">–</td> <td class="centered">–</td> </tr> <tr> <td class="subtitle2_left" colspan="4">LARC</td> </tr> <tr> <td class="indent1">LNG IUD 52/8 <span class="nowrap_whitespace">(Mirena<sup>¶</sup>/</span><span class="nowrap_whitespace">Liletta<sup>Δ</sup>)</span></td> <td class="centered">2 (1)</td> <td class="centered">7<sup>◊</sup> (5)</td> <td class="centered">14 (8)</td> </tr> <tr> <td class="indent1">LNG IUD 19.5/5 <span class="nowrap_whitespace">(Kyleena)<sup>§</sup></span></td> <td class="centered">2 (1)</td> <td class="centered">15 (5)</td> <td class="centered">–</td> </tr> <tr> <td class="indent1">LNG IUD 13.5/3 <span class="nowrap_whitespace">(Skyla)<sup>¥</sup></span></td> <td class="centered">4 (1)</td> <td class="centered">9 (3)</td> <td class="centered">–</td> </tr> <tr> <td class="indent1">TCu380A copper IUD (Paragard)</td> <td class="centered">8 (1)</td> <td class="centered">–</td> <td class="centered">14 (7); 22 (12)</td> </tr> <tr> <td class="indent1">Etonogestrel implant (Nexplanon)</td> <td class="centered">0.5 (1)</td> <td class="centered">4 (3); 6 (5)</td> <td class="centered">–</td> </tr> </tbody></table></div><div class="graphic_footnotes"><p>LARC: long-acting reversible contraception; LNG: levonorgestrel; IUD: intrauterine device.</p>
<p>* With three contiguous sites of fulguration along the fallopian tube (a total length of fulguration of approximately 3 cm).</p>
<p>¶ LNG-releasing IUD containing 52 mg LNG at initial placement and with an initial LNG release rate of 20 mcg/day for 8 years (Mirena).</p>
<p>Δ LNG-releasing IUD containing 52 mg LNG at initial placement and with an initial LNG release rate of 18.6 mcg/day for 8 years (Liletta).</p>
<p>◊ 5-year data is 7/1000 for Mirena and 8/1000 for Liletta; this is not statistically different.</p>
<p>§ LNG-releasing IUD containing 19.5 mg LNG at initial placement and with an initial LNG release rate of 17.5 mcg/day, which declines to 7.4 mcg/day at 5 years (Kyleena).</p>
¥ LNG-releasing IUD containing 13.5 mg LNG at initial placement and with an initial LNG release rate of 14 mcg/day for 3 years (Skyla).</div><div class="graphic_reference">References:
<ol>
<li>Peterson HB, Xia Z, Hughes JM, et al. The risk of pregnancy after tubal sterilization: findings from the U.S. Collaborative Review of Sterilization. Am J Obstet Gynecol 1996; 174:1161.</li>
<li>Peterson HB, Xia Z, Wilcox LS, et al. Pregnancy after tubal sterilization with bipolar electrocoagulation. U.S. Collaborative Review of Sterilization Working Group. Obstet Gynecol 1999; 94:163.</li>
<li>Rodriguez MI, Edelman AB, Kapp N. Postpartum sterilization with the titanium clip: a systematic review. Obstet Gynecol 2011; 118:143.</li>
<li>Lawrie TA, Kulier R, Nardin JM. Techniques for the interruption of tubal patency for female sterilization. Cochrane Database Syst Rev 2015; 9:CD003034.</li>
<li>Hatcher RA, Trussell J, Nelson AL, et al. Contraceptive Technology, 20th ed, Ardent Media, Inc, New York 2011.</li>
<li>Eisenberg DL, Schreiber CA, Turok DK, et al. Three-year efficacy and safety of a new 52-mg levonorgestrel-releasing intrauterine system. Contraception 2015; 92:10.</li>
<li>Nelson A, Apter D, Hauck B, et al. Two low-dose levonorgestrel intrauterine contraceptive systems: a randomized controlled trial. Obstet Gynecol 2013; 122:1205.</li>
<li>Sivin I, Stern J, Cutinho E, et. al. Prolonged intrauterine contraception: a seven-year randomized study of the levonorgestrel 20 mcg/day (LNg 20) and the Copper T380Ag IUDs. Contraception 1991; 44:473.</li>
<li>Bayer Pharmaceuticals. <a href="https://www.kyleenahcp.com/about-kyleena/efficacy" target="_blank">https://hcp.kyleena-us.com/about-kyleena/efficacy/</a> (Accessed on November 01, 2018).</li>
<li>Long-term reversible contraception. Twelve years of experience with the TCu380A and TCu220C. Contraception 1997; 56:341.</li>
<li>Jensen JT, Lukkari-Lax E, Schulze A, et al. Contraceptive efficacy and safety of the 52-mg levonorgestrel intrauterine system for up to 8 years: findings from the Mirena Extension Trial. Am J Obstet Gynecol 2022; 227:873.e1.</li>
<li>Creinin MD, Schreiber CA, Turok DK, et al. Levonorgestrel 52 mg intrauterine system efficacy and safety through 8 years of use. Am J Obstet Gynecol 2022; 227:871.e1.</li>
</ol></div><div id="graphicVersion">Graphic 54215 Version 10.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
